Skip to content
MukhyamantriMukhyamantri
Business

India could be on the radar for AstraZeneca’s oral GLP-1 drug: MD

AstraZeneca’s MD hints at India’s potential inclusion in global trials for its promising oral GLP-1 weight loss and diabetes drug.

By PT Jyothi Datta· BusinessLine· 4 months ago· 2 min read
India could be on the radar for AstraZeneca’s oral GLP-1 drug: MD

AstraZeneca’s MD hints at India’s potential inclusion in global trials for its promising oral GLP-1 weight loss and diabetes drug. For the full story, visit the source.

This summary is sourced from BusinessLine. Read the full article at:BusinessLine
#Astrazeneca#Clinical Trials#Diabetes#Glp-1#India#Pharma#Weight Loss